Cysteine rich peptide hydrogel in periodontal treatment

Evaluation of Locally Delivered Cysteine Rich Peptide Hydrogel in the Management of Periodontitis- A Randomised Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083666

Enrollment

Registered

2025-03-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Cysteine rich peptide: A Cysteine rich peptide hydrogel prepared by ionic dissolution method by incorporating L-cysteine as the main component and incorporating hyaluronic acid and plur

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with stage 2 grade B periodontitis Systemically healthy patients Normal occlusion No history of recent antibiotic intake

Exclusion criteria

Exclusion criteria: Advanced periodontitis Medically compromised patients Deleterious habits Parafunctional chewing habits Traumatic occlusion Recent antibiotic intake

Design outcomes

Primary

Measure	Time frame
Periodontal probing depth, Clinical attachment level, Plaque index, Gingival indexTimepoint: Baseline, 30 days	—

Secondary

Measure	Time frame
Quantitative assessment of Porphyromonas gingivalisTimepoint: Baseline, 30 days	—

Countries

India

Contacts

Public ContactDr Jaiganesh Ramamurthy

Saveetha Dental College and Hospitals

jaiganeshr@saveetha.com9840443463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026